Search results
Results from the WOW.Com Content Network
Marketed as Adalat CC in US, a 1995 US lawsuit found that Pfizer's Procardia XL was also based on Bayer's Adalat European and US patents. [30] [31] The use of nifedipine and related calcium channel antagonists was much reduced in response to 1995 trials that mortality was increased in patients with coronary artery disease who took nifedipine. [32]
Nifedipine (Procardia, Adalat) Nilvadipine (Nivadil) Nimodipine (Nimotop) This substance can pass the blood-brain barrier and is used to prevent cerebral vasospasm. Nisoldipine (Baymycard, Sular, Syscor) Nitrendipine (Cardif, Nitrepin, Baylotensin) Pranidipine (Acalas)
Dihydropyridine calcium channel blockers are derivatives of 1,4-dihydropyridine that are used as L-type calcium channel blockers. [1] They are used in the treatment of hypertension.
Medications to treat high blood pressure, such as Procardia and Adalat CC (nifedipine) Organ-transplant rejection drugs, including Sandimmune and Neoral (cyclosporine) Some anti-anxiety ...
Nifedipine (Procardia, Adalat) Ca 2+ channel blocker: Is one of the most commonly used tocolytic agents. [25] Hypotension, preload-dependent cardiac disease. [26] It should not be used concomitantly with magnesium sulfate [27] Flushing, headache, dizziness, nausea, transient hypotension. Administration of calcium channel blockers should be used ...
[1] [4] [5] The initial design developed in 1982 by ALZA researchers was designated the Push-Pull Osmotic Pump (PPOP), and Procardia XL was one of the first drugs to utilize this PPOP design. [1] [2] An animation illustrating the exterior/interior compositions of a tablet of Concerta, a PSOP OROS design.
Calcium channel blocker toxicity is the taking of too much of the medications known as calcium channel blockers (CCBs), either by accident or on purpose. [3] This often causes a slow heart rate and low blood pressure. [1]
The most studied and preferred medication for prevention of HAPE is nifedipine, [15] [3] a pulmonary vasodilator which prevents the altitude induced pulmonary hypertension. [16] The recommendation for its use is strongest for individuals with a history of HAPE.